| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.9M | -28.5% |
| Cost of Revenue | $2.0M | -22.0% |
| Gross Profit | $3.9M | -31.4% |
| R&D Expense | $2.8M | -14.3% |
| SG&A Expense | $5.0M | +13.0% |
| Operating Income | -$7.2M | -50.8% |
| Net Income | -$6.5M | -47.8% |
| EPS (Basic) | -$6.27 | -911.3% |
| EPS (Diluted) | -$6.27 | -911.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.7M | -59.3% |
| Accounts Receivable | $519K | -19.8% |
| Inventory | $1.6M | -3.4% |
| Current Assets | $20.9M | -13.5% |
| Total Assets | $21.4M | -13.2% |
| Current Liabilities | $1.2M | +12.1% |
| Total Liabilities | $1.3M | +1.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.1M | -15.0% |
| Capital Expenditures | $184K | +691.7% |
| Investing Cash Flow | $1.2M | +106.8% |
| Financing Cash Flow | $2.3M | -39.8% |
| Free Cash Flow | -$6.3M | -18.0% |
| Stockholders' Equity |
| $20.1M |
| -14.0% |